From: Multimodal therapy and twenty years of valid management of a patient with chronic hepatitis B in a less developed Western Region in China---case report and review of the literature
ALT(U/L)
AST(U/L)
TBIL (umol/L)
AFP(ng/ml)
CHE(IU/L)
LSM(kPa)
2013–11
43
50
46.2
< 10
5860
2014–10
40
53
48.1
6290
2016–06
54
51
6354
8.3
2017–12
64
40.3
6512
8.4